Embree Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Embree Financial Group's LLY Position: Q2 2026 in Review
Embree Financial Group reduced its Eli Lilly (LLY) stake by 0.36% in Q2 2026, selling an estimated $4.09K and leaving 1,093 shares worth $1.31M. The position accounts for 0.13% of the portfolio, ranked #102.
Embree Financial Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Embree Financial Group held 1,093 shares of Eli Lilly worth $1.31M as of Q2 2026.
- Embree Financial Group sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 0.13% of Embree Financial Group's portfolio in Q2 2026, its #102 holding.
- Embree Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.